United States· US:84685-300_5d5134f8-4b97-4e65-a18a-654744214b53
LEROCHOL
A lerodalcibep product containing lerodalcibep, registered in United States by LIB Therapeutics, Inc.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lerodalcibep is registered in 2 of 19 countries.
Countries holding a registration under ATC C10AX19 (lerodalcibep), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Lerodalcibep · ATC C10AX19
2 / 19 countries
- Finlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LERODALCIBEP
- Manufacturer
- LIB Therapeutics, Inc.
- Country
- United States (US)
- ATC code
- C10AX19
- ATC class
- Lerodalcibep
- Defined daily dose
- 4.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1184685-300-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lerodalcibep in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10ec237d-d8bc-44db-957a-bc12b6623282 GET /v1/drugs/10ec237d-d8bc-44db-957a-bc12b6623282?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "300",
"substance": "LERODALCIBEP",
"productndc": "84685-300",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1.2mL",
"application_number": "BLA761427",
"marketing_category": "BLA"
}See everything about lerodalcibep.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.